U.S. Paper and Forestry Products Stock News

NYSE:WFC
NYSE:WFCBanks

A Look At Wells Fargo (WFC) Valuation After Credit Concerns And Inflation Jitters Hit The Stock

What triggered the latest Wells Fargo move? Wells Fargo (WFC) shares dropped 6.6% after investors reacted to the bank’s reported exposure to Market Financial Solutions Ltd., a collapsed UK mortgage firm, alongside fresh concerns about inflation and broader credit risk. The sharp move has pushed the stock lower over the month and year to date. This has prompted many shareholders to reassess how this credit headline, together with rising macro worries, fits with the bank’s current valuation and...
NYSE:RIG
NYSE:RIGEnergy Services

How Transocean’s 2025 Loss and 2026 Revenue Outlook Could Reshape Transocean (RIG) Investors

In February 2026, Transocean Ltd. reported full-year 2025 results showing a US$2.92 billion net loss, while issuing 2026 guidance for contract drilling revenues of US$3.80 billion to US$3.95 billion and securing new offshore contracts in Brazil and Australia. The combination of a much larger loss, record adjusted EBITDA, and a growing backlog of high-spec offshore work highlights the contrast between Transocean’s current earnings pressure and its contract-driven revenue visibility. We’ll now...
NYSE:SYY
NYSE:SYYConsumer Retailing

Sysco Expands Local Sourcing And Coffee Partnership As Valuation Draws Interest

Sysco has launched a new pilot program, Home Grown by Sysco, to expand locally sourced food offerings across select regions in North America. The company has also signed a nationwide distribution partnership with Reborn Coffee to support the coffee brand's franchise expansion across the United States. For investors watching NYSE:SYY, these moves come as Sysco trades around $91.16 per share, with returns of 25.5% year to date and 23.8% over the past year. The stock has also returned 29.6%...
NYSE:PUMP
NYSE:PUMPEnergy Services

Why ProPetro (PUMP) Is Up 11.3% After Returning To Profit On Early ProPwr Traction

In February 2026, ProPetro Holding Corp. reported that it swung to a modest profit, posting fourth-quarter 2025 net income of US$742,000 and basic and diluted earnings per share from continuing operations of US$0.01, compared with a net loss of US$17.06 million and loss per share of US$0.17 a year earlier. For full-year 2025, ProPetro’s net income of US$824,000 and US$0.01 earnings per share from continuing operations marked a sharp turnaround from the prior year’s US$137.86 million loss and...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Why Intellia Therapeutics (NTLA) Is Up 9.0% After FDA Lifts MAGNITUDE-2 Hold And EPS Beat

In late February 2026, Intellia Therapeutics filed a US$26.84 million shelf registration for 2,000,000 common shares tied to its employee stock ownership plan, alongside reporting Q4 2025 results that exceeded earnings and revenue expectations. These updates, combined with the FDA lifting a clinical hold on the MAGNITUDE-2 trial and rapid Phase 3 enrollment for lonvo-z, underline how Intellia is progressing simultaneously on clinical, regulatory, and workforce-focused fronts. We’ll now...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Can Opendoor (OPEN) Turn Widening Losses Into a Stronger Unit-Economics Story?

In February 2026, Opendoor Technologies reported fourth-quarter 2025 results showing sales falling to US$736 million from US$1,084 million a year earlier, with quarterly net loss widening to US$1,096 million and management guiding to an approximate 10% quarter-over-quarter revenue decrease for first-quarter 2026. Despite lower revenue and larger losses for both the quarter and full year, management emphasized improving unit economics, faster inventory turns, and an October 2025 acquisition...
NasdaqGS:ONB
NasdaqGS:ONBBanks

A Look At Old National Bancorp’s (ONB) Valuation After Its Latest Dividend Increase

Old National Bancorp (ONB) recently increased its quarterly common stock dividend by 3.6% to $0.145 per share, a move that can draw income focused investors’ attention to how the stock currently trades. See our latest analysis for Old National Bancorp. Old National Bancorp’s latest dividend increase comes as the share price has been under short term pressure, with a 7 day share price return of 4.27% decline and a 30 day share price return of 5.44% decline. However, the 90 day share price...
NYSE:KO
NYSE:KOBeverage

Assessing Coca-Cola (KO) Valuation After Its 64th Consecutive Dividend Increase

Coca-Cola (KO) just approved its 64th consecutive annual dividend increase, lifting the quarterly payout by about 4% to $0.53 per share. This move directly targets income focused investors. See our latest analysis for Coca-Cola. At a share price of $81.56, Coca-Cola’s recent 30-day share price return of 9.02% and year to date gain of 18.00% suggest building momentum. The 5-year total shareholder return of 83.58% points to solid longer term compounding alongside the latest dividend increase...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Is Intapp’s New Agentic AI Platform Reshaping The Investment Case For Intapp (INTA)?

In February 2026, Intapp launched Intapp Celeste, a purpose-built agentic AI platform for professional firms, while expanding AI collaborations with Harvey and Anthropic’s Claude to embed governed, workflow-specific AI across its portfolio. This marks a shift toward AI agents acting as expert colleagues inside highly regulated workflows, enforcing ethical walls, handling sensitive data, and integrating deeply with tools like DealCloud, Microsoft 365, and Claude. We’ll explore how Intapp’s...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Is Now The Time To Reassess Upwork (UPWK) After Recent Share Price Slide

If you are wondering whether Upwork's recent share price swings have created an opportunity or a value trap, looking closely at what the market is actually pricing in can help frame your next move. Upwork's shares last closed at US$13.42, with a 7 day return of 7.3%, a 30 day return of a 33.0% decline, a year to date return of a 32.4% decline, a 1 year return of an 8.8% decline, a 3 year return of 12.5% and a 5 year return of a 68.2% decline. Recent attention on Upwork has centered on how...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Does Day One Biopharmaceuticals (DAWN) Share Price Reflect Its Oncology Pipeline Prospects?

If you are wondering whether Day One Biopharmaceuticals' current share price lines up with its underlying worth, you are not alone. The stock most recently closed at US$10.60, with a 7 day return of 10% decline, a 30 day return of 5% decline, gains of 19.8% year to date and 17% over the past year, while the 3 year return sits at 43.4% decline. Recent news around Day One has largely focused on its development stage oncology pipeline and ongoing progress in clinical programs, which can...
NYSE:PPL
NYSE:PPLElectric Utilities

Is It Too Late To Consider PPL (PPL) After Its Strong 1 Year Share Price Run?

If you are wondering whether PPL's share price still lines up with its underlying value, you are not alone. This article focuses on what the current price might be implying. PPL shares recently closed at US$38.98, with returns of 4.1% over 7 days, 7.5% over 30 days, 11.0% year to date and 14.3% over 1 year, while the 3 and 5 year returns sit at 57.8% and 67.2% respectively. Recent coverage around PPL has broadened investor attention to its role in the US utilities sector and how the company...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab Expands Defense Role And Space Power Ambitions With New Milestones

Rocket Lab completed a successful HASTE hypersonic test launch for the U.S. Defense Innovation Unit, supporting hypersonic systems development. The company introduced advanced silicon solar arrays aimed at powering large-scale, space-based data centers and mega-constellations. These developments expand Rocket Lab's role in national defense missions and in infrastructure for future orbital data and power needs. For investors watching NasdaqCM:RKLB, these updates sit alongside a current share...
NYSE:PFS
NYSE:PFSBanks

Do Provident Financial (PFS) Earnings Beat and Leadership Moves Reveal a New Commercial Banking Strategy?

Provident Financial Services recently reported fourth-quarter 2025 earnings that surpassed analyst expectations and highlighted a solid financial foundation, while director Robert E. McCracken sold 6,177 shares for US$136,697 and Provident Bank appointed Joseph A. Tammaro Jr. as executive vice president and head of middle market lending. Together, the earnings beat, insider transaction, and leadership hire in middle market banking give investors fresh information on profitability,...
NYSE:AEE
NYSE:AEEIntegrated Utilities

The Bull Case For Ameren (AEE) Could Change Following New Long‑Term Fixed‑Rate Debt Strategy Shift

Ameren Corporation recently completed several fixed‑income transactions, including a US$399.21 million offering of 5% senior notes due 2036, alongside earlier first mortgage bond issuances by Ameren Missouri to refinance short‑term debt and support grid investments. Together, these bond deals reshape Ameren’s funding mix by locking in long‑term, fixed‑rate capital and reducing refinancing uncertainty around its large infrastructure program. Next, we’ll explore how Ameren’s shift toward...
NYSE:WLK
NYSE:WLKChemicals

Does Westlake (WLK) Pair a 2025 Loss With Steadier Dividends To Reinforce Its Long-Term Narrative?

Westlake Corporation has reported weaker results for the fourth quarter and full year 2025, with sales falling to US$2,533 million and a quarterly net loss of US$544 million, alongside the planned retirement of long-serving Chief Financial Officer M. Steven Bender and the appointment of Bhavesh V. “Bob” Patel and CEO Jean-Marc Gilson to an expanded Board. Despite these earnings pressures and leadership changes, the Board’s decision to maintain a regular US$0.53 per-share dividend and the...
NYSE:APO
NYSE:APODiversified Financial

Apollo Global Management (APO) Is Down 8.0% After MidCap Dividend Cut And Credit Concerns Resurface

Apollo Global Management has recently faced pressure after Apollo-managed MidCap Financial Investment Corp. cut its dividend and marked down older assets, while a law firm began investigating potential securities issues tied to past executive discussions about tax arrangements with Jeffrey Epstein. These developments, alongside rising investor focus on credit quality in private-credit funds, have amplified concerns about how resilient Apollo’s broader platform may be to shifts in risk...
NasdaqGS:WERN
NasdaqGS:WERNTransportation

Werner Enterprises (WERN) Valuation Check After Annual Results And Recent Share Price Momentum

Werner Enterprises stock: event context and recent performance snapshot Werner Enterprises (WERN) has drawn investor attention after its latest reported annual results, which showed revenue of US$2.97b and a net loss of US$14.40m, alongside mixed share performance across the past year. See our latest analysis for Werner Enterprises. At a share price of US$35.09, Werner’s recent 90 day share price return of 29.10% and year to date gain of 14.64% point to building momentum. However, the 3 year...
NasdaqGM:VWAV
NasdaqGM:VWAVAerospace & Defense

How VisionWave’s NATO-Aligned Non-Explosive Drone Interceptor Push (VWAV) Has Changed Its Investment Story

VisionWave Holdings, Inc. recently signed a Memorandum of Understanding with a German aerospace systems provider and an Israeli interceptor drone developer to explore non-explosive interceptor drone solutions for the Bundeswehr and other German government entities, aligned with NATO-related rules-of-engagement and regulatory constraints. This early-stage cooperation highlights growing interest in alternative, non-explosive interception methods that seek to meet strict European defense...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Is Up 8.4% After SAPIEN M3 FDA Win And FTC Setback - Has The Bull Case Changed?

Edwards Lifesciences recently secured U.S. FDA approval for its SAPIEN M3 transcatheter mitral valve replacement system, issued 2026 sales guidance, and saw an FTC injunction block its planned JenaValve acquisition, while an EU antitrust investigation into its policies concluded. These developments collectively reduce legal uncertainty, highlight Edwards’ innovation in structural heart therapies, and align with its goal to broaden global access to cardiovascular treatments by 2030. We’ll now...
NYSE:SJM
NYSE:SJMFood

Assessing J. M. Smucker (SJM) Valuation After Recent Share Price Momentum

Recent share performance and business snapshot J. M. Smucker (SJM) has drawn investor attention after a period of steady gains, with the stock showing positive returns over the past week, month, past 3 months, year to date, and past year. The food and beverage group, which owns brands such as Folgers, Café Bustelo, Dunkin’, Jif, Smucker’s, Meow Mix, Milk-Bone and Hostess, now trades around $115.95 and reports annual revenue of about $8.9b. See our latest analysis for J. M. Smucker. The recent...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

A Look At PureCycle Technologies (PCT) Valuation After Record Output And Expansion Progress

PureCycle Technologies (PCT) has drawn fresh investor attention after reporting record fourth quarter production of PureFive recycled polypropylene, advancing its Thailand and Antwerp projects, and outlining a planned CFO transition. See our latest analysis for PureCycle Technologies. Despite record PureFive production and new partnerships, PureCycle’s recent price action has been weak, with a 1 month share price return of a 34% decline and a 1 year total shareholder return of a 38.74%...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

A Look At Diversified Healthcare Trust (DHC) Valuation After Earnings Reveal Narrower Net Loss

What the latest earnings tell you about Diversified Healthcare Trust Diversified Healthcare Trust (DHC) has just reported fourth quarter and full year 2025 results, showing lower quarterly sales but a narrower net loss, a combination that naturally puts the stock back on investors’ radar. See our latest analysis for Diversified Healthcare Trust. That earnings update landed after a strong run in the shares, with a 90 day share price return of 39.96% and a year to date share price return of...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Assessing Mercury Systems (MRCY) Valuation After Growth Update And Rising Defense Opportunities

Mercury Systems (MRCY) recently reported year over year growth in bookings, revenue, adjusted EBITDA, and backlog, supported by faster customer deliveries and factory automation investments, and outlined new opportunities linked to the defense budget. See our latest analysis for Mercury Systems. At a share price of US$89.03, Mercury Systems has seen a 33.28% 90 day share price return and a very large 100.47% 1 year total shareholder return, suggesting recent momentum has been strong as...